WO2022118077 - T-LYMPHOCYTE BINDING APTAMERS
National phase entry:
Publication Number
WO/2022/118077
Publication Date
09.06.2022
International Application No.
PCT/IB2021/000849
International Filing Date
03.12.2021
Title **
[English]
T-LYMPHOCYTE BINDING APTAMERS
[French]
APTAMÈRES DE LIAISON AUX LYMPHOCYTES T
Applicants **
AUMMUNE LTD.
Tel Aviv Medical Center (tamc)
Sammy Ofer Building, Floor 10
Weizmann St 6
Tel Aviv-yafo, IL
Inventors
NEEV, Guy
Katzenelson 75b
Bnei Dror, IL
CARMI-LEVY, Irit
Weizmann St 6
6423906 Tel Aviv, IL
LAVI, Erez
10 Devora Omer St.
8155838 Yavne, IL
ZILONY-HANIN, Neta
Weizmann St 6
6423906 Tel Aviv, IL
PODE, Zohar
1 Carlebach 4c
Tel Aviv, IL
REISS, Neria
305 Hagefen Street
71935 Dolev, IL
GLAICH, Ohad
Katzenelson 75b
Givatayim, IL
FARHI, Ronit
Tel Tsvi St 36
Pardes Hanna, IL
Priority Data
63/121,080
03.12.2020
US
63/257,402
19.10.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 3999 | |
| EPO | Filing, Examination | 62495 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 607 | |
| USA | Filing, Examination | 24910 |
Total: 92602 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Provided herein are aptamers that target T-lymphocytes and methods of use thereof.[French]
La présente invention concerne des aptamères qui ciblent des lymphocytes T et leurs méthodes d'utilisation.